≡ Menu ≡ Menu

Zantac Recall Claim: Have You Or A Loved Suffered From Cancer After Using Recalled Zantac or Ranitidine?

Zantac recall Ranitidine recalled lawsuit cases

If you or a loved one have suffered from cancer after using Zantac or Ranitidine that was recalled, you may be entitled to recover compensation from a Zantac recall lawsuit or settlement.

A team of drug injury lawyers and class action attorneys is investigating potential product recall lawsuit and settlement cases of individuals who claim to have suffered from cancer after taking heartburn medications Zantac or Ranitidine that have been the subject of a recall.

Zantac Recall Lawsuit Claims

Zantac recall lawsuit and settlement cases potentially being investigated include claims of individuals who have suffered from certain types of cancer after taking Zantac or ranitidine that was recalled.

On April 1, 2020, the U.S. Food and Drug Administration (FDA) announced that it had requested that manufacturers withdraw and remove all prescription and over-the-counter (OTC) ranitidine drugs (such as a Zantac) from the market following its investigation relating to a possible N-Nitrosodimethylamine or NDMA contamination.

The FDA reportedly determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity. According to the FDA, NDMA is a probable human carcinogen (i.e., it could cause cancer in humans).

Zantac & Ranitidine Recalls

Certain manufacturers and distributors had already issued Zantac recalls in the months prior to the FDA’s April 1, 2020 announcement. For example, on September 23, 2019, the FDA announced that Sandoz Inc. issued a recall of ranitidine hydrochloride capsules due to an elevated amount of unexpected impurity N-nitrosodimethylamine (NDMA).

On September 25, 2019 the FDA announced that Apotex Corp. issued a recall of ranitidine tablets 75mg and 150mg sold at Walgreens (Wal-Zan® Ranitidine Tablets, Acid Reducer), Walmart (Ranitidine tablets acid reducer), and Rite-Aid (Ranitidine tablets) due to the potential for detection of an amount of unexpected NDMA impurity.

On October 18, 2019, Sanofi announced a recall of Zantac OTC (over-the-counter) in the United States and Canada due to possible contamination nitrosamine impurity.  On October 23, 2019, Perrigo Company plc announced a ranitidine recall.

On October 25, 2019, Lannett Company, Inc. announced a recall of Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/mL. 

On October 25, 2019, Novitium Pharma LLC announced a recall of Ranitidine Hydrochloride Capsules (150 mg and 300 mg).

On November 6, 2019, Aurobindo Pharma USA initated a nationwide recall of certain Ranitidine Tablets 150mg and Ranitidine Capsules 150mg, Ranitidine Capsules 300mg and Ranitidine Syrup 15mg/mL due to the detection of NDMA (Nitrosodimethylamine) Impurity.

On November 8, 2019, Amneal Pharmaceuticals, LLC announced it was recalling Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP).

On November 8, 2019, American Health Packaging announced that was recalling certain lots of Ranitidine Syrup (Ranitidine Oral Solution USP) 150 mg/10 mL Liquid Unit Dose Cups due to NDMA (Nitrosodimethylamine) impurity.

If you or someone you love have suffered from cancer after taking recalled Zantac or Ranitidine, you may be entitled to compensation from a Zantac recall lawsuit case or settlement claim. Contact a drug injury lawyer to request a free case review.

*If you or a loved one are experiencing health issues, side effects or complications after taking a prescription drug or medication, we urge you to promptly consult with your doctor or physician for an evaluation.

**The listing of a company (e.g., Sandoz, Sanofi, Apotex, Perrigo, Lannett, Novitium, Amneal Pharmaceuticals, Aurobindo Pharma or American Health Packaging) or product (e.g., Zantac or Ranitidine) is not meant to state or imply that the company acted illegally or improperly or that the product is unsafe or defective; rather only that an investigation may be, is or was being conducted to determine whether legal rights have been violated.

***The use of any trademarks, tradenames or service marks is solely for product identification and/or informational purposes.

Fill out the form for a free attorney review.